Results 161 to 170 of about 145,114 (299)
AI-Driven fetal distress monitoring SDN-IoMT networks. [PDF]
Ullah A +4 more
europepmc +1 more source
Foundations for enhanced maternity data collection and reporting in Australia: national maternity data development project - stage 1 [PDF]
Findings from a project aimed at building a more comprehensive and consistent national data collection for maternal and perinatal health are presented in this report.
core
Immunomodulatory and Cytotoxic Properties of Enniatin B1 in Porcine Alveolar Macrophages
ABSTRACT This study investigates the immunomodulatory effects of Enniatin B1 (ENNB1), an emerging mycotoxin, on porcine alveolar macrophages (PAMs), a species‐specific model relevant to human innate immunity. PAMs were exposed to increasing ENNB1 concentrations (0.5–6 μM) over 6, 24, and 48 h.
Sara Frazzini +4 more
wiley +1 more source
Klippel‐Trénaunay‐Weber Syndrome: Prenatal Diagnosis and Review of the Literature
This meta‐analysis demonstrates the high diagnostic accuracy of SZ‐CEUS for differentiating between malignant and benign focal liver lesions, as well as for HCC from non‐HCC lesions. The study shows better performance for smaller lesions and those with a higher proportion of malignancy.
Giuliana Orlandi +13 more
wiley +1 more source
Fetal Distress as a Determinant for Refeeding Syndrome in Preterm Neonates. [PDF]
Di Chiara M +7 more
europepmc +1 more source
Abstract Background Vaccination has been proposed as a potential risk factor for autism spectrum disorder (ASD), contributing to public hesitancy and mistrust toward immunization. Influenza vaccination during pregnancy is considered safe and effective in preventing serious maternal complications and adverse birth outcomes associated with influenza ...
Shahar Neeman +4 more
wiley +1 more source
Evaluation and Association of Meconium-Stained Amniotic Fluid With Fetal Distress. [PDF]
Karpe NS, Tagad MB, Holkar RR, More VS.
europepmc +1 more source
Abstract Objectives This study aims to quantify the levels of relaxin 2 (RLX2), oxytocin (OXT), and insulin‐like peptide 3 (INSL3) in colostrum (postpartum days 1–5, Visit 1) and mature breast milk (postpartum days 21–35, Visit 2), and to evaluate their associations with neonatal growth outcomes.
Hakan Doneray +3 more
wiley +1 more source

